Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EV / Sales (ltm)

Arbutus Biopharma Cp EV / Sales (ltm) Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EV / Sales (ltm) from 2010 to 2018.
  • Arbutus Biopharma Cp EV / Sales (ltm) for the quarter ending March 03, 2018 was 19.70 a -350.73% decrease of -69.09 year over year
  • Arbutus Biopharma Cp Annual EV / Sales (ltm) for 2017 was 25.32 a 88.84% increase of 22.49 from 2016
  • Arbutus Biopharma Cp Annual EV / Sales (ltm) for 2015 was 2.83 a -347.50% decrease of -9.82 from 2014
  • Arbutus Biopharma Cp Annual EV / Sales (ltm) for 2014 was 12.65 a 21.91% increase of 2.77 from 2013
Other Valuation Metrics:
  • Arbutus Biopharma Cp Market Cap for the quarter ending March 03, 2018 was $275m a 28.06% increase of 77m year over year
  • Arbutus Biopharma Cp Price / Book for the quarter ending March 03, 2018 was 2.07 a 49.51% increase of 1.03 year over year
  • Arbutus Biopharma Cp Enterprise Value for the quarter ending March 03, 2018 was $211m a 52.69% increase of 111m year over year
View Chart On Koyfin

Quarterly ABUS EV / Sales (ltm) Data

03/201819.70
12/201725.32
09/2017135.00
06/201788.79
03/201740.42
09/20161.31
06/20160.84
03/20161.78
12/20152.83
09/20157.35

Annual ABUS EV / Sales (ltm) Data

201725.32
20152.83
201412.65
20139.88
20124.50
20110.51
20101.74